Journal
JOURNAL OF IMMUNOLOGY
Volume 200, Issue 9, Pages 3087-3099Publisher
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.1701179
Keywords
-
Categories
Funding
- National Institutes of Health [R01 AI058150]
- Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health
Ask authors/readers for more resources
Mouse models of lupus have shown that multiple immune cell types contribute to autoimmune disease. This study sought to investigate the involvement of B cells and dendritic cells in supporting the expansion of inflammatory and regulatory CD4(+) T cells that are critical for lupus pathogenesis. We used lupus-prone B6.NZM2410.Sle1.Sle2.Sle3 (TC) and congenic C57BL/6J (B6) control mice to investigate how the genetic predisposition of these two cell types controls the activity of normal B6 T cells. Using an allogeneic in vitro assay, we showed that TC B1-a and conventional B cells expanded Th17 cells significantly more than their B6 counterparts. This expansion was dependent on CD86 and IL-6 expression and mapped to the Sle1 lupus-susceptibility locus. In vivo, TC B cells promoted greater differentiation of CD4(+) T cells into Th1 and follicular helper T cells than did B6 B cells, but they limited the expansion of Foxp3 regulatory CD4(+) T cells to a greater extent than did B6 B cells. Finally, when normal B6 CD4(+) T cells were introduced into Rag1(-/)-mice, TC myeloid/stromal cells caused their heightened activation, decreased Foxp3 regulatory CD4(+) T cell differentiation, and increased renal infiltration of Th1 and Th17 cells in comparison with B6 myeloid/stromal cells. The results show that B cells from lupus mice amplify inflammatory CD4(+) T cells in a nonredundant manner with myeloid/stromal cells.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available